Cure My Disease

Don't miss your cure!

 Log in / Sign up

Remote leg strength test could change PAD monitoring

NCT ID NCT07497360

Knowledge-focused Sponsor: Izmir Democracy University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a simple leg strength test, the 30-second sit-to-stand test, gives the same results when done over a video call as in person. Researchers will enroll 45 adults with peripheral artery disease (PAD) to compare both methods. If remote testing proves reliable, it could make follow-up care easier for patients who have trouble traveling to clinics.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could show that remote assessments are reliable for monitoring leg strength in PAD patients, making follow-up care more convenient.
What could go wrong
This is a small, early-stage study with only 45 participants, so results may not apply to all PAD patients. The study does not test a treatment, only a measurement method.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients diagnosed with peripheral artery disease, aged 18 to 65 years.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged between 18 and 65 years * Diagnosed with peripheral artery disease, Fontaine stage I-II, confirmed by peripheral angiography or Doppler ultrasonography * Willingness to participate in the study * Access to a smartphone and the internet Exclusion Criteria: * Presence of orthopedic, neurological, or psychological conditions that limit physical activity * Neurological or musculoskeletal disorders affecting standing or walking * History of ischemic amputation * Acute inflammatory condition * Use of walking aids * Visual or hearing impairment * Vestibular system disorder * Cognitive impairment affecting cooperation * Severe cardiopulmonary diseases limiting walking ability * Major surgery or myocardial infarction within the last three months * Unstable coronary artery disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Peripheral arterial disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Peripheral arterial disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dokuz Eylul University Faculty of Medicine

    RECRUITING

    Izmir, Balçova, 35330, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.